It will be of interest to evaluate the effect of manipulating MCP-1 levels in AML in future studies and to further characterize BM-MSCs with abnormal cytogenetics and the influence of reduced cytokine production in a hypoxic BME on leukemia stem cell quiescence. This evidence concerns the gene CCL2 and leukemia.